Beacon Investment Advisory Services’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $415K | Sell |
7,200
-14
| -0.2% | -$804 | 0.02% | 198 |
|
|
2026
Q1 | $438K | Sell |
7,214
-274
| -4% | -$16K | 0.02% | 194 |
|
|
2025
Q4 | $404K | Sell |
7,488
-175
| -2% | -$8.42K | 0.02% | 193 |
|
|
2025
Q3 | $346K | Sell |
7,663
-400
| -5% | -$18.7K | 0.01% | 205 |
|
|
2025
Q2 | $373K | Hold |
8,063
| – | – | 0.02% | 194 |
|
|
2025
Q1 | $492K | Buy |
8,063
+212
| +3% | +$12.4K | 0.02% | 167 |
|
|
2024
Q4 | $444K | Sell |
7,851
-300
| -4% | -$16.8K | 0.02% | 178 |
|
|
2024
Q3 | $422K | Sell |
8,151
-1,500
| -16% | -$70.4K | 0.02% | 188 |
|
|
2024
Q2 | $401K | Sell |
9,651
-249
| -3% | -$11.1K | 0.02% | 191 |
|
|
2024
Q1 | $537K | Sell |
9,900
-3,287
| -25% | -$167K | 0.02% | 173 |
|
|
2023
Q4 | $677K | Sell |
13,187
-7,983
| -38% | -$419K | 0.03% | 161 |
|
|
2023
Q3 | $1.23M | Sell |
21,170
-600
| -3% | -$36.8K | 0.06% | 139 |
|
|
2023
Q2 | $1.39M | Sell |
21,770
-4,625
| -18% | -$310K | 0.06% | 142 |
|
|
2023
Q1 | $1.83M | Sell |
26,395
-115
| -0.4% | -$8.11K | 0.09% | 127 |
|
|
2022
Q4 | $1.91M | Sell |
26,510
-717
| -3% | -$54.1K | 0.1% | 123 |
|
|
2022
Q3 | $1.94M | Buy |
27,227
+242
| +0.9% | +$17.6K | 0.11% | 121 |
|
|
2022
Q2 | $2.08M | Buy |
26,985
+55
| +0.2% | +$4.19K | 0.11% | 128 |
|
|
2022
Q1 | $1.97M | Sell |
26,930
-694
| -3% | -$46.6K | 0.08% | 128 |
|
|
2021
Q4 | $1.72M | Sell |
27,624
-3,176
| -10% | -$186K | 0.07% | 141 |
|
|
2021
Q3 | $1.82M | Sell |
30,800
-3,265
| -10% | -$215K | 0.08% | 140 |
|
|
2021
Q2 | $2.28M | Sell |
34,065
-1,396
| -4% | -$91K | 0.09% | 131 |
|
|
2021
Q1 | $2.24M | Buy |
35,461
+1,000
| +3% | +$62.2K | 0.1% | 132 |
|
|
2020
Q4 | $2.14M | Buy |
34,461
+395
| +1% | +$24.3K | 0.1% | 132 |
|
|
2020
Q3 | $2.05M | Buy |
34,066
+102
| +0.3% | +$6.14K | 0.11% | 124 |
|
|
2020
Q2 | $2M | Sell |
33,964
-74
| -0.2% | -$4.43K | 0.11% | 123 |
|
|
2020
Q1 | $1.9M | Buy |
34,038
+252
| +0.7% | +$15.4K | 0.13% | 114 |
|
|
2019
Q4 | $2.17M | Buy |
33,786
+21,453
| +174% | +$1.23M | 0.12% | 125 |
|
|
2019
Q3 | $625K | Sell |
12,333
-1,400
| -10% | -$65.8K | 0.06% | 140 |
|
|
2019
Q2 | $623K | Sell |
13,733
-17,551
| -56% | -$818K | 0.07% | 126 |
|
|
2019
Q1 | $1.49M | Sell |
31,284
-24,665
| -44% | -$1.23M | 0.16% | 95 |
|
|
2018
Q4 | $2.91M | Sell |
55,949
-2,998
| -5% | -$161K | 0.32% | 74 |
|
|
2018
Q3 | $3.66M | Sell |
58,947
-5,746
| -9% | -$341K | 0.36% | 70 |
|
|
2018
Q2 | $3.58M | Sell |
64,693
-2,638
| -4% | -$142K | 0.36% | 72 |
|
|
2018
Q1 | $4.26M | Buy |
67,331
+18,231
| +37% | +$1.17M | 0.44% | 64 |
|
|
2017
Q4 | $3.01M | Sell |
49,100
-3,092
| -6% | -$193K | 0.32% | 84 |
|
|
2017
Q3 | $3.33M | Buy |
+52,192
| New | +$3.05M | 0.29% | 90 |
|
|
2016
Q3 | – | Sell |
-3,646
| Closed | -$268K | – | 73 |
|
|
2016
Q2 | $268K | Buy |
3,646
+73
| +2% | +$5.16K | 0.06% | 59 |
|
|
2016
Q1 | $228K | Hold |
3,573
| – | – | 0.05% | 59 |
|
|
2015
Q4 | $246K | Sell |
3,573
-500
| -12% | -$33K | 0.05% | 55 |
|
|
2015
Q3 | $241K | Buy |
+4,073
| New | +$258K | 0.04% | 55 |
|
Other funds holding BMY
AIM
FWIA
DLA
ETC
Beacon Investment Advisory Services's BMY Position: Q2 2026 in Review
Beacon Investment Advisory Services reduced its Bristol-Myers Squibb (BMY) stake by 0.19% in Q2 2026, selling an estimated $804 and leaving 7,200 shares worth $415K. The position accounts for 0.02% of the portfolio, ranked #198.
Beacon Investment Advisory Services first reported a position in BMY in Q3 2015 and has held it in 40 quarters since. The position peaked at $4.26M in Q1 2018. 879 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Beacon Investment Advisory Services held 7,200 shares of Bristol-Myers Squibb worth $415K as of Q2 2026.
- Beacon Investment Advisory Services sold 14 Bristol-Myers Squibb shares in Q2 2026, an estimated $804.
- Bristol-Myers Squibb made up 0.02% of Beacon Investment Advisory Services's portfolio in Q2 2026, its #198 holding.
- Beacon Investment Advisory Services first reported a position in Bristol-Myers Squibb in Q3 2015 and has held it in 40 quarters since.
- Beacon Investment Advisory Services's Bristol-Myers Squibb position peaked at $4.26M in Q1 2018.
- 879 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Beacon Investment Advisory Services's 13F filing for Q2 2026, filed 8 Jul 2026.